Insights

Innovative Technology Platform TISSIUM specializes in proprietary biomorphic, programmable polymers for tissue reconstruction, creating opportunities to collaborate on customized medical devices and tissue engineering solutions.

Expanding Application Scope The company is actively exploring new therapeutic areas such as nerve repair, indicating potential for partnerships in developing advanced reconstruction products for diverse clinical needs.

Recent Product Launches With the launch of the COAPTIUM Connect Sutureless Nerve Coaptation System and successful clinical studies, there is a clear market focus on innovative, minimally invasive tissue repair solutions.

Strategic Funding Growth Having secured $50 million in Series D funding, TISSIUM is positioned for scaling its product portfolio and expanding commercialization efforts, creating sales opportunities across multiple regions.

Strong Industry Engagement Participation in global conferences and active collaboration with medtech leaders suggest an openness to partnerships and joint ventures that can enhance market penetration and technology deployment.

Similar companies to TISSIUM

TISSIUM Tech Stack

TISSIUM uses 8 technology products and services including MATLAB, RSS, Open Graph, and more. Explore TISSIUM's tech stack below.

  • MATLAB
    Advanced Analytics And Data Science
  • RSS
    Content Management System
  • Open Graph
    Content Management System
  • OpenAI
    Generative Ai
  • Microsoft Word
    Office Suites
  • LinkedIn
    Online Community Software
  • OVHcloud
    Platform As A Service
  • Yoast SEO
    Search Engines

Media & News

TISSIUM's Email Address Formats

TISSIUM uses at least 1 format(s):
TISSIUM Email FormatsExamplePercentage
FLast@tissium.comJDoe@tissium.com
94%
First.Last@tissium.comJohn.Doe@tissium.com
4%
Last.First@tissium.comDoe.John@tissium.com
1%
FirstL@tissium.comJohnD@tissium.com
1%

Frequently Asked Questions

Where is TISSIUM's headquarters located?

Minus sign iconPlus sign icon
TISSIUM's main headquarters is located at 74 Rue du Faubourg Saint-antoine Paris, Île-de-france 75012 France. The company has employees across 4 continents, including EuropeNorth AmericaAsia.

What is TISSIUM's official website and social media links?

Minus sign iconPlus sign icon
TISSIUM's official website is tissium.com and has social profiles on LinkedInCrunchbase.

What is TISSIUM's NAICS code?

Minus sign iconPlus sign icon
TISSIUM's NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does TISSIUM have currently?

Minus sign iconPlus sign icon
As of June 2026, TISSIUM has approximately 146 employees across 4 continents, including EuropeNorth AmericaAsia. Key team members include Chief Medical Officer: A. M.Chief Innovation Officer: M. P.Chief Financial Officer: R. A.. Explore TISSIUM's employee directory with LeadIQ.

What industry does TISSIUM belong to?

Minus sign iconPlus sign icon
TISSIUM operates in the Medical Equipment Manufacturing industry.

What technology does TISSIUM use?

Minus sign iconPlus sign icon
TISSIUM's tech stack includes MATLABRSSOpen GraphOpenAIMicrosoft WordLinkedInOVHcloudYoast SEO.

What is TISSIUM's email format?

Minus sign iconPlus sign icon
TISSIUM's email format typically follows the pattern of FLast@tissium.com. Find more TISSIUM email formats with LeadIQ.

When was TISSIUM founded?

Minus sign iconPlus sign icon
TISSIUM was founded in 2013.

TISSIUM

Medical Equipment ManufacturingÎle-de-france, France51-200 Employees

TISSIUM is a mid-sized medical equipment manufacturer based in Paris, founded in 2013 to address the challenge of reconstructing damaged tissue and restoring its natural function after surgery. It has built a technology platform anchored by proprietary materials and delivery approaches to support tissue reconstruction across multiple therapeutic areas. The firm operates an integrated model for innovation, design, commercialization and manufacturing to back its internal programs and co-development partnerships with leaders in the medtech industry.

The company collaborates with clinicians and medtech partners to advance tissue reconstruction solutions for surgical applications and to broaden its platform's reach. It continues to pursue expansion of its platform to additional applications, including nerve repair, with clinical data related to peripheral nerve repair presented in 2025. In 2026, TISSIUM appointed Marc Quartulli as Vice President of Clinical Affairs, reflecting ongoing development of its clinical strategy and operations.

Section iconCompany Overview

Headquarters
74 Rue du Faubourg Saint-antoine Paris, Île-de-france 75012 France
NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Founded
2013
Employees
51-200

Section iconFunding & Financials

  • $1M$10M

    TISSIUM's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1M$10M

    TISSIUM's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.